EDITORIAL
Published on 06 Jul 2023
Editorial: Functional screening for cancer drug discovery: from experimental approaches to data integration
doi 10.3389/fgene.2023.1201454
- 2,096 views
- 2 citations
- Frontiers in Genetics
- Cancer Genetics and Oncogenomics
- Research Topics
- Functional screening for cancer drug discovery: from experimental approaches to data integration
Functional screening for cancer drug discovery: from experimental approaches to data integration
19k
Total downloads
47k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 23 Jan 2023
The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
doi 10.3389/fgene.2023.1039813
- 2,101 views
- 4 citations
ORIGINAL RESEARCH
Published on 07 Dec 2022
Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity
doi 10.3389/fgene.2022.1004467
- 2,169 views
- 2 citations
ORIGINAL RESEARCH
Published on 28 Sep 2022
A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening
doi 10.3389/fgene.2022.942166
- 1,860 views
- 4 citations
ORIGINAL RESEARCH
Published on 26 Sep 2022
Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancer
doi 10.3389/fgene.2022.969856
- 3,320 views
- 14 citations
ORIGINAL RESEARCH
Published on 29 Aug 2022
A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity
doi 10.3389/fgene.2022.939956
- 3,559 views
- 17 citations
ORIGINAL RESEARCH
Published on 25 Jul 2022
Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma
doi 10.3389/fgene.2022.900713
- 1,944 views
- 5 citations
ORIGINAL RESEARCH
Published on 22 Jul 2022
Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis
doi 10.3389/fgene.2022.907331
- 3,307 views
- 14 citations
ORIGINAL RESEARCH
Published on 25 Nov 2021
POLR2A Promotes the Proliferation of Gastric Cancer Cells by Advancing the Overall Cell Cycle Progression
doi 10.3389/fgene.2021.688575
- 4,013 views
- 12 citations
REVIEW
Published on 08 Jul 2021
Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy
doi 10.3389/fgene.2021.691391
- 8,280 views
- 29 citations
